Blavatnik Biomedical Accelerator
Pre-Proposal Deadlines: September 11, 2020 for Pilot applications and January 8, 2021 for Development and Pilot applications
Award Amount: $100,000 for 1 year for Pilot grants; $300,000 for 2 years for Development grants

The Blavatnik Biomedical Accelerator at Harvard University provides essential gap funding, development support, and business expertise to help faculty investigators achieve the full potential of their work. The Accelerator seeks to support innovative, investigator-initiated research, and to develop preliminary observations into robust intellectual property positions. Its primary goal is to advance technologies to the point where an industry partnership can commence. Proposals are welcomed from Harvard principal investigators with early-stage research in a range of life science areas, including therapeutics, diagnostics, drug delivery technologies, medical devices/instruments, and enabling technologies for drug discovery. Pilot Grants are intended to support proof-of-concept activities that (if successful) would establish a basis for a subsequent Development Grant proposal. Development Grants are expected to generate partnerable technology within the proposed timeframe.

Only one pre-proposal per applicant will be accepted per cycle. Based on recommendations from the Accelerator Advisory Committee and OTD, a subset of applicants will be invited to submit a full proposal. We strongly recommend that all applicants work with the Office of Technology Development (OTD) and the Blavatnik Biomedical Accelerator (BBA) team to develop a strong pre-proposal. Anu Natajaran, BBA Senior Associate Director, is available to meet virtually. To set up a meeting to discuss your proposal idea, please contact Dr. Natajaran at anuradha_natarajan@harvard.edu or blavatnik_accelerator@harvard.edu.